ESR1 and breast cancer: Suo et al. [11] found that MCF-7 and T47-D breast cancer cells responsive to hormonal therapy were ER- and HER4-positive and that MDA-MD-231 and SK-BR-3 cells nonresponsive to hormonal therapy were ER- and HER4-negative.